SEC Form 4 · accession 0001209191-18-058039
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael S. Cuffe
Officer — President-Physician Services
Period of report
Nov 7, 2018
Accepted (ET)
Nov 9, 2018 · 7:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 7, 2018 | M | 12,325 | $47.97 | A | 33,240 | D | |
| Common Stock | Nov 7, 2018 | F | 7,382 | $141.65 | D | 25,858 | D | |
| Common Stock | Nov 9, 2018 | S | 4,943 | $141.90 | D | 20,915 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightF2 | $47.97 | Nov 7, 2018 | M | 12,325 | D | — | Feb 5, 2024 | Common Stock | 12,325 | 0 | D |
Explanation of responses
- F1The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.